SCHEDULE 13G/A: BlackRock Discloses 12.5% Beneficial Ownership in Silicon Laboratories Inc.

Sentiment:

Beneficial Ownership Disclosure


BlackRock, Inc. has filed an updated Schedule 13G, revealing a 12.5% beneficial ownership stake in Silicon Laboratories Inc., totaling over 4 million shares.

Summary

  • BlackRock, Inc. reported beneficial ownership of 4,046,624 shares of Common Stock in Silicon Laboratories Inc.
  • This ownership represents 12.5% of the class of securities outstanding.
  • BlackRock holds sole voting power over 4,005,498 shares and sole dispositive power over 4,046,624 shares.
  • The filing is an Amendment No. 17 to a Schedule 13G, indicating a passive investment position.
  • BlackRock, Inc. is identified as a parent holding company or control person, with its principal business office located at 50 Hudson Yards, New York, NY 10001.
  • BlackRock Fund Advisors is specifically noted as an entity beneficially owning 5% or greater of the outstanding shares of the security class.

Sentiment

Score: 6

Explanation: The document is a routine disclosure of a significant passive ownership stake by a major institutional investor, which is generally a neutral to slightly positive signal for the company, indicating confidence from a large fund.

Positives

  • BlackRock, Inc., a major institutional investor, holds a significant 12.5% stake in Silicon Laboratories Inc., which can be interpreted as a vote of confidence in the company's long-term prospects.

Industry Context

This filing reflects a standard disclosure by a major asset manager, BlackRock, Inc., regarding its significant passive investment in a publicly traded technology company, Silicon Laboratories Inc. Such disclosures are routine for large institutional investors managing diverse portfolios.

Stakeholder Impact

  • Shareholders may view BlackRock's significant stake as a positive indicator of institutional confidence in Silicon Laboratories Inc., potentially influencing investment decisions.

Key Dates

DateDescription
2025-01-21Date of execution for the Power of Attorney, revoking a previous one from April 30, 2023.
2025-03-31Date of event which requires the filing of this statement.
2025-04-28Date the Schedule 13G was signed and filed.

Keywords

BlackRock, Silicon Laboratories Inc., Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Passive Investment, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.